Literature DB >> 21401575

Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis.

J K Mulligan1, B S Bleier, B O'Connell, R M Mulligan, C Wagner, R J Schlosser.   

Abstract

Vitamin D(3) (VD(3) ) is a steroid hormone that regulates bone health and numerous aspects of immune function and may play a role in respiratory health. We hypothesized that T helper type 2 (Th2) disorders, chronic rhinosinusitis with nasal polyps (CRSwNP) and allergic fungal rhinosinusitis (AFRS) would have VD(3) deficiencies, resulting in increased mature dendritic cells (DCs) and bone erosion. We conducted a retrospective study examining VD(3) levels in patients with AFRS (n = 14), CRSwNP (n = 9), chronic rhinosinusitis without nasal polyps (CRSsNP) (n = 20) and cerebrospinal fluid leak repair (non-diseased controls) (n = 14) at time of surgery. Circulating immune cell levels were determined by immunostaining and flow cytometric analysis. Plasma VD(3) and immune regulatory factors (granulocyte-macrophage colony-stimulating factor and prostaglandin E(2) ) were measured by enzyme-linked immunosorbent assay. It was observed that CRSwNP and AFRS demonstrated increased circulating DCs, while chronic rhinosinusitis without nasal polyps displayed increased circulating macrophages. CRSwNP and AFRS were to found to have insufficient levels of VD(3) which correlated inversely with circulating numbers of mature DCs, DC regulatory factors and bone erosion. CRSsNP displayed no change in circulating DC numbers or VD(3) status compared to control, but did display increased numbers of circulating macrophages that was independent of VD(3) status. Lastly, VD(3) deficiency was associated with more severe bone erosion. Taken together, these results suggest support a role for VD(3) as a key player in the immunopathology of CRSwNP and AFRS.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401575      PMCID: PMC3087926          DOI: 10.1111/j.1365-2249.2011.04325.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice.

Authors:  M Okano; M Azuma; T Yoshino; H Hattori; M Nakada; A R Satoskar; D A Harn; E Nakayama; T Akagi; K Nishizaki
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

Review 2.  Dendritic cells: emerging pharmacological targets of immunosuppressive drugs.

Authors:  Holger Hackstein; Angus W Thomson
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

Review 3.  Allergen-specific pattern recognition receptor pathways.

Authors:  Marsha Wills-Karp
Journal:  Curr Opin Immunol       Date:  2010-11-17       Impact factor: 7.486

4.  Proinflammatory cytokines in acute asthma.

Authors:  P H Brown; G K Crompton; A P Greening
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

5.  1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.

Authors:  G Penna; L Adorini
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

6.  Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro.

Authors:  Elizabeth J Soilleux; Lesley S Morris; George Leslie; Jihed Chehimi; Qi Luo; Ernest Levroney; John Trowsdale; Luis J Montaner; Robert W Doms; Drew Weissman; Nicholas Coleman; Benhur Lee
Journal:  J Leukoc Biol       Date:  2002-03       Impact factor: 4.962

7.  Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses.

Authors:  P Kaliński; C M Hilkens; A Snijders; F G Snijdewint; M L Kapsenberg
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

8.  Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  Naomi Yamashita; Hiroyuki Tashimo; Hirobumi Ishida; Fujito Kaneko; Junichi Nakano; Hiroshi Kato; Koichi Hirai; Tadashi Horiuchi; Ken Ohta
Journal:  Cell Immunol       Date:  2002-10       Impact factor: 4.868

9.  Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia.

Authors:  Mirella Profita; Angelo Sala; Anna Bonanno; Loredana Riccobono; Liboria Siena; Mario R Melis; Rossana Di Giorgi; Franco Mirabella; Mark Gjomarkaj; Giovanni Bonsignore; Antonio M Vignola
Journal:  J Allergy Clin Immunol       Date:  2003-10       Impact factor: 10.793

10.  Diagnosis of allergic fungal sinusitis.

Authors:  J P Bent; F A Kuhn
Journal:  Otolaryngol Head Neck Surg       Date:  1994-11       Impact factor: 3.497

View more
  21 in total

1.  Vitamin D regulation of OX40 ligand in immune responses to Aspergillus fumigatus.

Authors:  Nikki Lynn Hue Nguyen; Kong Chen; Jeremy McAleer; Jay K Kolls
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

Review 2.  Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.

Authors:  Mauricio López-Chacón; Joaquim Mullol; Laura Pujols
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

3.  Vitamin D3 as a novel regulator of basic fibroblast growth factor in chronic rhinosinusitis with nasal polyposis.

Authors:  E Ritter Sansoni; Nathan B Sautter; Jess C Mace; Timothy L Smith; James R Yawn; Lauren A Lawrence; Rodney J Schlosser; Zachary M Soler; Jennifer K Mulligan
Journal:  Int Forum Allergy Rhinol       Date:  2015-01-05       Impact factor: 3.858

4.  Vitamin D deficiency is associated with increased human sinonasal fibroblast proliferation in chronic rhinosinusitis with nasal polyps.

Authors:  William W Carroll; Rodney J Schlosser; Brendan P O'Connell; Zachary M Soler; Jennifer K Mulligan
Journal:  Int Forum Allergy Rhinol       Date:  2016-01-11       Impact factor: 3.858

5.  The relationship between Th1/Th2 balance and 1α,25-dihydroxyvitamin D₃ in patients with nasal polyposis.

Authors:  Sule Ozkara; Erol Keles; Nevin Ilhan; Hilal Gungor; Irfan Kaygusuz; Hayrettin Cengiz Alpay
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-23       Impact factor: 2.503

Review 6.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

7.  Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: Secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial.

Authors:  Junfang Jiao; Tonya S King; Matthew McKenzie; Leonard B Bacharier; Anne E Dixon; Christopher D Codispoti; Ryan M Dunn; Nicole L Grossman; Njira L Lugogo; Sima K Ramratnam; Russell S Traister; Michael E Wechsler; Mario Castro
Journal:  J Allergy Clin Immunol       Date:  2016-03-11       Impact factor: 10.793

8.  The presence of CD209 expressing dendritic cells correlates with biofilm positivity in chronic rhinosinusitis with nasal polyposis.

Authors:  Tamás Karosi; Péter Csomor; Zoltán Hegyi; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-29       Impact factor: 2.503

Review 9.  New insights into upper airway innate immunity.

Authors:  Benjamin M Hariri; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2016-09       Impact factor: 2.467

10.  Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey.

Authors:  Sadeq A Quraishi; Edward A Bittner; Kenneth B Christopher; Carlos A Camargo
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.